Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$6.30
-2.55%
Mkt Cap $1.60B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $2.24M | $5.48M | +144.50% | -$0.11 | -$0.08 | +27.27% | — | — |
| Q4 2025 Nov 4, 2025 | $1.89M | — | — | -$0.09 | -$0.09 | +0.00% | — | — |
| Q3 2025 Aug 12, 2025 | $1.73M | $1.99M | +14.88% | -$0.07 | -$0.09 | -28.57% | — | — |
| Q2 2025 May 15, 2025 | $1.08M | $2.30M | +112.31% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q1 2025 Feb 26, 2025 | $2.05M | $2.02M | -1.51% | -$0.08 | -$0.07 | +12.50% | — | — |
| Q4 2024 Nov 13, 2024 | $2.05M | $1.79M | -12.90% | -$0.08 | -$0.09 | -12.50% | — | — |
| Q3 2024 Aug 12, 2024 | $2.66M | $1.11M | -58.20% | -$0.10 | -$0.09 | +10.00% | — | — |
| Q2 2024 May 14, 2024 | $2.56M | $3.41M | +33.24% | -$0.11 | -$0.10 | +9.09% | — | — |
| Q1 2024 Mar 19, 2024 | $2.65M | $3.60M | +36.00% | -$0.09 | $0.35 | +488.89% | — | — |
| Q4 2023 Nov 14, 2023 | $2.65M | $4.75M | +79.09% | -$0.13 | -$0.13 | +0.00% | — | — |
| Q3 2023 Aug 14, 2023 | $1.05M | $2.40M | +128.10% | -$0.31 | -$0.38 | -22.58% | — | — |
| Q2 2023 May 11, 2023 | $70.00K | $4.71M | +6622.86% | -$0.35 | -$0.28 | +20.00% | — | — |
| Q1 2023 Mar 28, 2023 | $8.18M | $2.50M | -69.41% | -$0.41 | -$0.99 | -141.46% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.89 | -$0.64 | +28.09% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$1.05 | -$0.84 | +20.00% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$1.04 | -$1.31 | -25.96% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$1.21 | -$1.32 | -9.09% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$1.02 | -$1.35 | -32.35% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.81 | -$1.09 | -34.57% | — | — |
| Q2 2021 May 11, 2021 | — | — | — | -$0.54 | -$0.87 | -61.11% | — | — |